Glycolysis module activated by hypoxia-inducible factor 1α is related to the aggressive phenotype of hepatocellular carcinoma
Takashi Hamaguchi,Norio Iizuka,Ryouichi Tsunedomi,Yoshihiko Hamamoto,Takanobu Miyamoto,Michihisa Iida,Yoshihiro Tokuhisa,Kazuhiko Sakamoto,Motonari Takashima,Takao Tamesa,Masaaki Oka +10 more
TL;DR: Activation of an HIF-1alpha-regulated glycolysis module is closely related to the aggressive phenotype of HCC, and that ENO1, a glycoleysis module gene, might serve as a new target to circumvent HCC metastasis.
read more
Abstract: An increased level of glycolysis, an intracellular hallmark of neoplasms, enables cancer cells to survive under various conditions. To elucidate the role of increased glycolysis in the progression of hepatocellular carcinoma (HCC), we investigated the associations between the expression patterns of 14 glycolysis-related genes and clinicopathologic factors in 60 HCCs by using pooled transcriptome data. We then evaluated the therapeutic efficacy of the knockdown of ENO1, which is encoded by a glycolysis-related gene, in HCC cells. Among the 14 genes, levels of 8 genes (GPI, ALDOA, TPI1, GAPD, PGK, PGAM, ENO1 and PKM), all of which can be transcriptionally activated by hypoxia-inducible factor 1alpha (HIF-1alpha), were significantly higher in HCC with venous invasion (VI) than in HCC without VI. Our cluster analysis showed that HCC patients with activation of the 8 HIF-1alpha-regulated genes had significantly shorter overall survival (P=0.023) than did HCC patients without increased expression levels of these genes. The association between the levels of ENO1 and VI was confirmed in an independent sample set of 49 HCCs by real-time reverse-transcription PCR. The knockdown of ENO1 by small-interfering RNA significantly inhibited the proliferation of an HCC cell line (HLE cells) in both the glucose-rich and glucose-free conditions, accompanied by a decreased S phase and increased G2/M phase of the cell cycle. Collectively, these data suggest that activation of an HIF-1alpha-regulated glycolysis module is closely related to the aggressive phenotype of HCC, and that ENO1, a glycolysis module gene, might serve as a new target to circumvent HCC metastasis.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Novel Biomarkers in Pancreatic Cancer
Simona Dima,Cristiana Tanase,Radu Albulescu,Anca Botezatu,Irinel Popescu +4 more
- 28 Mar 2012
TL;DR: Simona O. Dima, Cristiana Tanase, Radu Albulescu, Anca Botezatu, and Irinel Popescu present data from a double-bypass Liver Transplantation study at the Romanian Academy ‘Stefan S. Nicolau’ Virology Institute.
Papillary renal cell carcinomas rewire glutathione metabolism and are deficient in anabolic glucose synthesis
Alahmad A,Alahmad A,Paffrath,Rosanna Clima,Rosanna Clima,Jonas Busch,Anja Rabien,Ergin Kilic,Villegas S,Bernd Timmermann,Marcella Attimonelli,Klaus Jung,David Meierhofer +12 more
TL;DR: It is suggested that impaired metabolism and dysfunctional mitochondria determine the fate of papillary renal cell carcinomas and it is proposed that the specific regulation of the mitochondrial respiratory chain can differentiate highly similar malignant pRCCs from benign renal oncocytomas.
Development and verification of the glycolysis-associated and immune-related prognosis signature for hepatocellular carcinoma
TL;DR: The developed gene signature acted as the independent factor, which was significantly associated with clinical stage, grade, portal vein invasion, and intrahepatic vein invasion among HCC cases, and the model showed high efficiency.
4
Lysine acetyltransferase 6A maintains CD4+ T cell response via epigenetic reprogramming of glucose metabolism in autoimmunity.
Jia-Yao Fu,Shi-Jia Huang,Bao-Li Wang,Jun-Hao Yin,Chang-Yu Chen,Jia-Bao Xu,Yan-Lin Chen,Shuo Xu,Ting Dong,Hao-Nan Zhou,Xin-Yi Ma,Yi-Ping Pu,Hui Li,Xiu-Juan Yang,L. Xie,Zhi-Jun Wang,Qi Luo,Yan-Xiong Shao,Lei Ye,Zirui Zong,Xin-Di Wei,Wanwen Xiao,Shu-Tong Niu,Yi-Ming Liu,He-Ping Xu,Chuang-Qi Yu,Shengzhong Duan,Ling-Yan Zheng +27 more
TL;DR: It is shown that lysine acetyltransferase 6A (KAT6A), an epigenetic modulator that is clinically associated with autoimmunity, orchestrates the metabolic reprogramming of glucose in CD4+ T cells.
4
References
Cluster analysis and display of genome-wide expression patterns
TL;DR: A system of cluster analysis for genome-wide expression data from DNA microarray hybridization is described that uses standard statistical algorithms to arrange genes according to similarity in pattern of gene expression, finding in the budding yeast Saccharomyces cerevisiae that clustering gene expression data groups together efficiently genes of known similar function.
Quantitative monitoring of gene expression patterns with a complementary DNA microarray.
TL;DR: A high-capacity system was developed to monitor the expression of many genes in parallel by means of simultaneous, two-color fluorescence hybridization, which enabled detection of rare transcripts in probe mixtures derived from 2 micrograms of total cellular messenger RNA.
10.9K
Targeting HIF-1 for cancer therapy
TL;DR: Hypoxia-inducible factor 1 (HIF-1) activates the transcription of genes that are involved in crucial aspects of cancer biology, including angiogenesis, cell survival, glucose metabolism and invasion.
6.7K
Hypoxia — a key regulatory factor in tumour growth
TL;DR: Cells undergo a variety of biological responses when placed in hypoxic conditions, including activation of signalling pathways that regulate proliferation, angiogenesis and death, and many elements of the hypoxia-response pathway are good candidates for therapeutic targeting.
5.3K
Why do cancers have high aerobic glycolysis
TL;DR: In this article, the authors propose that persistent metabolism of glucose to lactate even in aerobic conditions is an adaptation to intermittent hypoxia in pre-malignant lesions, which leads to microenvironmental acidosis requiring evolution to phenotypes resistant to acid-induced cell toxicity.
4.8K